Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Added mentions of Multiple Myeloma and related topics (MedlinePlus Genetics) and the revision note 'Revision: v3.3.2'. The PubMed publications boilerplate was revised with a note 'Revision: v3.2.0'.
    Difference
    0.1%
    Check dated 2025-11-25T13:59:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/status notice banner at the top.
    Difference
    0.2%
    Check dated 2025-11-18T07:22:02.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page no longer shows the topic 'Multiple Myeloma' and omits the related topic 'MedlinePlus Genetics'. This reduces the disease-focused context and keyword associations used for discovery.
    Difference
    0.3%
    Check dated 2025-10-27T20:55:35.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic on multiple myeloma (a core medical topic).
    Difference
    0.1%
    Check dated 2025-10-20T17:12:30.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic for multiple myeloma, expanding core content with genetics information about this disease.
    Difference
    0.1%
    Check dated 2025-10-13T11:56:14.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    - Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T07:57:11.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.